Hitting SARS-CoV-2 in a new spot A key target for therapeutic antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the spike protein, a trimeric protein complex with each monomer comprising an S1 and an S2 domain that mediate binding to host cells and membrane fusion, respectively. In addition to the receptor binding domain (RBD), S1 has an N-terminal domain (NTD). In searching for neutralizing antibodies, there has been a focus on the RBD. Chi et al. isolated antibodies from 10 convalescent patients and identified an antibody that potently neutralizes the virus but does not bind the RBD. Cryo–electron microscopy revealed the epitope as the NTD. This NTD-targeting antibody may be useful to combine with RBD-targeting antibodies in therapeutic cocktails. Science , this issue p. 650 A region outside of the receptor binding domain of SARS-CoV-2 is targeted by a neutralizing antibody. Developing therapeutics against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) could be guided by the distribution of epitopes, not only on the receptor binding domain (RBD) of the Spike (S) protein but also across the full Spike (S) protein. We isolated and characterized monoclonal antibodies (mAbs) from 10 convalescent COVID-19 patients. Three mAbs showed neutralizing activities against authentic SARS-CoV-2. One mAb, named 4A8, exhibits high neutralization potency against both authentic and pseudotyped SARS-CoV-2 but does not bind the RBD. We defined the epitope of 4A8 as the N-terminal domain (NTD) of the S protein by determining with cryo–eletron microscopy its structure in complex with the S protein to an overall resolution of 3.1 angstroms and local resolution of 3.3 angstroms for the 4A8-NTD interface. This points to the NTD as a promising target for therapeutic mAbs against COVID-19.
【초록키워드】 COVID-19, neutralizing antibody, SARS-CoV-2, coronavirus, Neutralizing antibodies, spike, antibody, monoclonal antibody, Local, virus, Receptor binding domain, Protein, Epitopes, Neutralizing activity, RBD, Microscopy, therapeutic, membrane fusion, NTD, distribution, epitope, mAbs, convalescent patient, binding, mAb, convalescent COVID-19 patients, N-terminal domain, host cell, Science, acute respiratory syndrome, complex, neutralization potency, monomer, protein complex, S2 domain, pseudotyped SARS-CoV-2, neutralize, trimeric, defined, addition, characterized, the spike protein, the RBD, Developing, the S protein, exhibit, the Spike, RBD-targeting antibody, 【제목키워드】 SARS-CoV-2, antibody, Protein, Neutralizing, N-terminal domain, bind, the Spike,